These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3879803)

  • 21. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 22. The clinical significance of the in vivo antinuclear antibody phenomenon.
    Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
    Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antinuclear factors. Clinical and humoral correlations; diagnostic importance].
    Purice S; Gheorghiu M; Ghelerter L; Drăgoi T
    Med Interna (Bucur); 1969 Oct; 21(10):1205-40. PubMed ID: 4189145
    [No Abstract]   [Full Text] [Related]  

  • 25. [Value of the characterization of anti-ribonucleoproteins and anti-Sm antibodies by immunoblotting and immunoprecipitation in connectivitis].
    Combe B; Lussiez V; Rucheton M; Graafland H; Brunel C; Sany J
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):47-9. PubMed ID: 3281242
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anti-ENA antibody and nephropathy--cases of MCTD and SLE].
    Yoshida A; Shinmura I; Morozumi K; Oikawa T; Fujinami T; Matsumoto Y; Nakamura S; Gotoh I; Sohmiya S
    Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):221-8. PubMed ID: 3488441
    [No Abstract]   [Full Text] [Related]  

  • 27. [Do antinuclear antibodies precede systemic lupus?].
    Aho K; Koskela P; Mäkitalo R; Heliövaara M; Palosuo T
    Duodecim; 1992; 108(2):157-60. PubMed ID: 1365996
    [No Abstract]   [Full Text] [Related]  

  • 28. Anticentromere antibodies--clinical correlates.
    Wade JP; Sack B; Schur PH
    J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Laboratory diagnosis of polysystemic autoimmune diseases].
    Sipka S
    Orv Hetil; 2005 Feb; 146(9):403-9. PubMed ID: 15830607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy in mixed connective tissue disease: comparison with systemic lupus erythematosus.
    Kaufman RL; Kitridou RC
    J Rheumatol; 1982; 9(4):549-55. PubMed ID: 6182291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N; Bosković B
    Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibodies to denatured DNA detected by millipore filter assay in patients with SLE and other rheumatic diseases (author's transl)].
    Sarai T; Miyawaki S; Kurata N; Ofuji T
    Ryumachi; 1978 Sep; 18(5):335-43. PubMed ID: 310165
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blastic lymphocyte transformation in lupus erythematosus and scleroderma].
    Pawińska M; Gliński W; Blaszczyk M; Wranicz A
    Przegl Dermatol; 1973; 60(2):161-6. PubMed ID: 4134109
    [No Abstract]   [Full Text] [Related]  

  • 35. Anticentromere antibodies: clinical and biological significance.
    Fritzler MJ; Ayer LM
    J Rheumatol; 1982; 9(4):489-90. PubMed ID: 6982333
    [No Abstract]   [Full Text] [Related]  

  • 36. Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations.
    Greidinger EL; Casciola-Rosen L; Morris SM; Hoffman RW; Rosen A
    Arthritis Rheum; 2000 Apr; 43(4):881-8. PubMed ID: 10765934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease.
    Whicher JT; Gilbert AM; Westacott C; Hutton C; Dieppe PA
    Clin Exp Immunol; 1986 Jul; 65(1):80-9. PubMed ID: 3491701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 39. Mixed connective tissue disease (MCTD)--its immunological characteristics.
    Chorzelski T; Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):779-82. PubMed ID: 312087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
    J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.